Diseases, Conditions, Syndromes

Hepatitis C testing, treatment down during the pandemic

(HealthDay)—The COVID-19 pandemic reduced routine hepatitis C virus (HCV) testing and treatment, according to a study published online May 10 in the American Journal of Preventive Medicine.

Diseases, Conditions, Syndromes

Levels of hepatitis C virus higher among African-Americans and males

Epidemiologists have determined that levels of hepatitis C virus (HCV) found among injection drug users (IDUs) were higher in individuals who are male or African American even after differences in other factors were considered. ...

Diseases, Conditions, Syndromes

Only half newly reported HCV cases receiving follow-up test

(HealthDay)—The lack of a hepatitis C virus (HCV) RNA test for approximately one-half of persons newly reported as HCV infected suggests that testing and reporting must improve to detect all persons with current infection, ...

Diseases, Conditions, Syndromes

More progress needed for hep C elimination in country of Georgia

(HealthDay)—More interventions are needed to meet the target of hepatitis C virus (HCV) elimination, defined as a 90 percent reduction in prevalence by 2020, in the country of Georgia, according to research published in ...

Diseases, Conditions, Syndromes

Study quantifies prevalence of chronic HCV infection

(HealthDay)—The prevalence of hepatitis C virus (HCV) infection is about 1 percent, with 2.7 million U.S. residents estimated as having chronic HCV infection, according to a study published in the March 4 issue of the Annals ...

Diseases, Conditions, Syndromes

Hepatitis C: A novel point-of-care assay

One of the major challenges identified by the WHO in efforts to eradicate the hepatitis C virus (HCV) is the diagnosis of chronic cases that are generally asymptomatic. Major progress is required for new diagnostic techniques ...

page 2 from 3